The solid investment-grade ratings on Amgen Inc. reflect the strong performance of the company's newer products, the growing diversity of its drug portfolio, and its conservative financial policies. At the same time, the ratings are constrained by uncertainties about Amgen's still relatively narrow drug offering.
- Arthur Wong
HTML Medium Image Quote Embed:
HTML Large Image Quote Embed:
HTML Text Quote Embed with <blockquote>:
BB Forums Medium Image Quote Embed with <BB Code>:
Please login in order to submit reports.